UA100864C2 - Спосіб лікування або запобігання аневризмі черевної аорти - Google Patents

Спосіб лікування або запобігання аневризмі черевної аорти

Info

Publication number
UA100864C2
UA100864C2 UAA201005772A UAA201005772A UA100864C2 UA 100864 C2 UA100864 C2 UA 100864C2 UA A201005772 A UAA201005772 A UA A201005772A UA A201005772 A UAA201005772 A UA A201005772A UA 100864 C2 UA100864 C2 UA 100864C2
Authority
UA
Ukraine
Prior art keywords
prevention
treatment
abdominal aortic
aortic aneurysms
compounds
Prior art date
Application number
UAA201005772A
Other languages
English (en)
Russian (ru)
Inventor
Жан-Баптісте Мікель
Original Assignee
Астразенека Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астразенека Аб filed Critical Астразенека Аб
Publication of UA100864C2 publication Critical patent/UA100864C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Abstract

Винахід стосується способу лікування або запобігання аневризмі черевної аорти із застосуванням {1S-[1α,2α,3β(1S*,2R*)-5β]}-3-(7-{[2-(3,4-дифлуорфеніл)циклопропіл]аміно}-5-(пропілтіо)-3Н-1,2,3-триазоло[4,5-d]піримідин-3-іл)-5-(2-гідроксіетокси)циклопентан-1,2-діолу.
UAA201005772A 2007-12-03 2008-02-12 Спосіб лікування або запобігання аневризмі черевної аорти UA100864C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07301616 2007-12-03
PCT/SE2008/051386 WO2009072967A1 (en) 2007-12-03 2008-12-02 Triazolo [4,5-d] pyrimidine compounds for treatment of abdominal aortic aneurysms

Publications (1)

Publication Number Publication Date
UA100864C2 true UA100864C2 (uk) 2013-02-11

Family

ID=40717966

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201005772A UA100864C2 (uk) 2007-12-03 2008-02-12 Спосіб лікування або запобігання аневризмі черевної аорти

Country Status (25)

Country Link
US (2) US20100298350A1 (uk)
EP (1) EP2229172B1 (uk)
JP (1) JP5701060B2 (uk)
KR (1) KR101563757B1 (uk)
CN (2) CN101883565A (uk)
AU (1) AU2008331984B2 (uk)
BR (1) BRPI0819458A2 (uk)
CA (1) CA2707488C (uk)
CY (1) CY1115760T1 (uk)
DK (1) DK2229172T3 (uk)
EA (1) EA201000928A1 (uk)
ES (1) ES2522317T3 (uk)
HK (1) HK1148195A1 (uk)
HR (1) HRP20141081T1 (uk)
IL (1) IL205613A (uk)
MX (1) MX2010006101A (uk)
MY (1) MY159656A (uk)
NZ (1) NZ585513A (uk)
PL (1) PL2229172T3 (uk)
PT (1) PT2229172E (uk)
RS (1) RS53635B1 (uk)
SI (1) SI2229172T1 (uk)
UA (1) UA100864C2 (uk)
WO (1) WO2009072967A1 (uk)
ZA (1) ZA201003599B (uk)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102653539B (zh) * 2011-03-01 2014-09-17 秦引林 一种抗血小板聚集化合物及其药物组合
CN102924457A (zh) * 2011-08-12 2013-02-13 上海恒瑞医药有限公司 三唑并嘧啶类衍生物、其制备方法及其用途
US9539246B2 (en) 2011-08-30 2017-01-10 University Of Utah Research Foundation Methods and compositions for treating nephrogenic diabetes insipidus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL182680B1 (pl) * 1995-07-11 2002-02-28 Astrazeneca Ab Nowe inhibitory skupiania się płytek krwi
TW530058B (en) * 1997-07-22 2003-05-01 Astra Pharma Prod Triazolo [4,5-d]pyrimidine compounos and their use and process for preparation
TWI229674B (en) * 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB0013407D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Forms of a chemical compound
SE0101932D0 (sv) * 2001-05-31 2001-05-31 Astrazeneca Ab Pharmaceutical combinations
WO2009007675A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist

Also Published As

Publication number Publication date
NZ585513A (en) 2012-07-27
SI2229172T1 (sl) 2014-12-31
WO2009072967A1 (en) 2009-06-11
KR20100099175A (ko) 2010-09-10
CN101883565A (zh) 2010-11-10
CA2707488A1 (en) 2009-06-11
PL2229172T3 (pl) 2015-01-30
BRPI0819458A2 (pt) 2015-05-05
EA201000928A1 (ru) 2010-12-30
EP2229172B1 (en) 2014-09-10
PT2229172E (pt) 2014-11-03
ZA201003599B (en) 2012-10-31
HRP20141081T1 (hr) 2015-01-02
CN103919781A (zh) 2014-07-16
DK2229172T3 (da) 2014-11-10
AU2008331984A1 (en) 2009-06-11
MY159656A (en) 2017-01-13
US20100298350A1 (en) 2010-11-25
IL205613A0 (en) 2010-11-30
EP2229172A1 (en) 2010-09-22
JP2011505417A (ja) 2011-02-24
ES2522317T3 (es) 2014-11-14
KR101563757B1 (ko) 2015-10-27
EP2229172A4 (en) 2012-12-26
CY1115760T1 (el) 2017-01-25
AU2008331984B2 (en) 2012-08-16
MX2010006101A (es) 2010-10-04
IL205613A (en) 2015-04-30
JP5701060B2 (ja) 2015-04-15
US20150272955A1 (en) 2015-10-01
CA2707488C (en) 2015-07-28
RS53635B1 (en) 2015-04-30
HK1148195A1 (en) 2011-09-02

Similar Documents

Publication Publication Date Title
TNSN07323A1 (en) Imidazo (1, 2-a) pyridine compounds as vegf-r2 inhibitors
HRP20130660T1 (en) Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
IL204693A0 (en) Imidazo[1, 2 - a] pyrimidine derivatives for the treatment of diseases such as diabetes
AP2010005346A0 (en) 3H-[1,2,3]triazolo[4,5-D]pyrimidine compounds, their use as mTOR kinase and P13 kinase inhibitors, and their synthesis.
TN2011000220A1 (en) Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
UA99597C2 (uk) Піримідилциклопентани як інгібітори акт протеїнкіназ
ZA201004368B (en) Pyrazolo [1,5-a] pyrimidines useful as jak2 inhibitors
WO2007059257A3 (en) N4-phenyl-quinaz0line-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
MY147364A (en) Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
HK1118534A1 (en) Thieno-pyrimidine compounds having fungicidal activity
AP2241A (en) Pyrimidine derivatives for the treatment of abnormal cell growth.
MX2011006334A (es) Polimorfos de (s)-3-amino-metil-7-(3-hidroxi-propoxi)-3h-benzo-[c] [1,2]-oxaborol-1-ol.
WO2007100610A3 (en) Pyridine, pyrimidine and pyrazine derivatives as cxcr3 receptor modulators
MY169738A (en) Fused bicyclic pyrimidines
TNSN07440A1 (en) Derivatives of pyrido [2,3 -d] pyrimidine, the preparation thereof, and the therapeutic application of the same
WO2005097799A8 (en) Pyrazolo`4,3-d! pyrimidines
WO2008060693A3 (en) Tetracyclic imidazole analogs
WO2007146813A3 (en) Pyridinone analogs as cell proliferation inhibitors
UA100864C2 (uk) Спосіб лікування або запобігання аневризмі черевної аорти
SG152296A1 (en) Novel process for the preparation of 5-amino-3h-thiazolo[4,5-d]pyrimidin-2- one
TW200714284A (en) Novel method
WO2007087246A3 (en) Jak2 tyrosine kinase inhibition
TW200732342A (en) Process for the preparation of purified crystalline CCI-779
UA97235C2 (uk) Похідні хіназоліну та конденсованого піримідину як інгібітори erbb
CL2008002376A1 (es) Procedimiento de preparacion de compuestos derivados de 3-piperidin-4-il-1,3,4,5-tetrahidro-benzo(d)(1,3)diazepin-2-ona; compuestos intermediarios; y su procedimiento de preparacion